Moderna Investors Relieved By Infringement Settlement -- Market Talk
Dow Jones
8 hours ago
1350 ET - Moderna shares rise 14% as its patent-infringement settlement was better than investors feared, William Blair analysts say in a note. Investors were contemplating the impact of the legislation being close to $5 billion, which could have raised liquidity concerns, the analysts say. The settlement also creates more certainty for funding late-stage oncology developments in 2026, which look like long-term growth drivers, they say. The analysts maintain their market perform rating but are more constructive on the stock as more clearing events like this one occur. (katherine.hamilton@wsj.com)
(END) Dow Jones Newswires
March 04, 2026 13:50 ET (18:50 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.